NEW DELHI: Drug agency Hetero on Wednesday stated it has launched generic oral antiviral drug Favipiravir used for the remedy of sufferers with gentle to reasonable Covid-19, in India below the model identify ‘Favivir’ at Rs 59 per pill. The […]
The corporate has been granted the manufacturing and advertising and marketing approval for Favipiravir from the Drug Controller Basic of India (DCGI), Hetero stated in an announcement.
Coronavirus outbreak: Stay updates
Favivir is the second drug developed by Hetero after Covifor (Remdesivir) used within the remedy of Covid-19, it added.
The remedy has demonstrated optimistic medical outcomes. It improves remedy accessibility to a big quantity of Covid-19 affected person inhabitants, which have gentle to reasonable signs, Hetero stated.
“Favivir is priced at Rs 59 per pill and is marketed and distributed by Hetero Healthcare Ltd. The product is out there from at this time in any respect retail medical shops and hospital pharmacies throughout the nation and will probably be bought solely on prescription,” it added.
Extra on Covid-19
The drug, being manufactured on the firm’s formulation facility within the nation, has been authorised by stringent international regulatory authorities, Hetero stated.